Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Josh Mandel-Brehm, MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER, CAMP4 THERAPEUTICS
Don't Be Afraid of the Dark Genome: New Therapies from Regulatory Non-Coding RNA
Cambridge, Massachusetts, United States
Placeholder Photo
Henning Mann, PhD
BUSINESS DEVELOPMENT, NIKON BIOIMAGING LAB
Nikon BioImaging Lab
Cambridge, Massachusetts, United States
Lydia Mann Kline, MPH, MS
TEAM LEAD, CLINICAL RESEARCH POLICY OFFICE OF SCIENCE POLICY, NATIONAL INSTITUTES OF HEALTH
Thou Shalt Not Pass? How to Navigate the Latest Policies on Cross-Border Data Flow
Meredith Manning
PRESIDENT, THE AMERICAS, PHARMAESSENTIA USA
Y-Not: Are There Leadership Advantages Women Bring to the Biopharma C-Suite?
Elizabeth Mansfield
VICE PRESIDENT OF REGULATORY POLICY, FOUNDATION MEDICINE
In Vitro Diagnostics Regulation in the US and Beyond: Trends and Strategies to Navigate Change
Li Mao, MD
VICE PRESIDENT, GENERAL MANAGER OF RESEARCH AND DEVELOPMENT AND CHIEF MEDICAL OFFICER, SCICLONE PHARMACEUTICALS
The Future of Combination Therapies for Cancer Treatment
John Maraganore
FORMER FOUNDING CEO AND A DIRECTOR, ALNYLAM
Biotech Hangout
Ian Marks
DIRECTOR, STRATEGY & SOLUTIONS, HEALTHCARE AND LIFE SCIENCES, AMAZON WEB SERVICES
Meeting Patients' Needs Through Innovative Digital Tools
Peter Marks, MD, PhD
DIRECTOR, CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), U.S. FOOD AND DRUG ADMINISTRATION
Friend or Foe: How COVID-19 Changed the Dynamic with Global Regulatory Agencies
FDA Town Hall
Realizing the Promise of Gene Therapy and Gene Editing: Current Challenges, Opportunities and Trends
Silver Spring, Maryland, United States
Placeholder Photo
Timothy Marlowe
CHIEF SCIENTIFIC OFFICER, FAKNOSTICS, LLC
FAKnostics, LLC